Andersch et al. employed CAR-T cells co-targeting both L1CAM and the GD2 ganglioside in retinoblastoma cell lines, and reported that this approach led to elimination of tumor cells in vitro [135]. This evidence concerns the gene L1CAM and retinoblastoma.